Results 61 to 70 of about 159,655 (310)

Technological sanctions, research capacity, and unintended consequences

open access: yesInternational Review of Economics & Finance
This study examines the impact of technological sanctions on global competition, highlighting that their outcomes depend significantly on the research capacities of the targeted countries.
Chu-Ping Lo
doaj   +1 more source

Feasibility and Preliminary Efficacy of Integrative Neuromuscular Training for Childhood Cancer Survivors: A Pilot Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of childhood acute lymphoblastic leukemia (ALL) often exhibit early deficits in muscle and movement competence, which can compromise long‐term health. Integrative neuromuscular training (INT), a multifaceted approach combining fundamental movement activities with strength exercises, may help address these deficits during ...
Anna Maria Markarian   +7 more
wiley   +1 more source

Targeted Financial Sanctions and the Evolving European Union AML/CFT Framework

open access: yesBratislava Law Review
This paper aims to examine two recent legislative initiatives of the European Union (EU)—the 6th AML Directive and the new AML Regulation, focusing particularly on the provisions that reform targeted financial sanctions as part of the EU's anti-money ...
Georgios Pavlidis
doaj   +1 more source

The relevance of time in framing the sanctions framework for defective disclosure [PDF]

open access: yes, 2017
Sanctions imposed on listed companies in cases of breached disclosure obligations have steadily but rather slowly been moving towards a harmonized approach in EU corporate law. Without compromising the potential efficiency of these harmonisation measures,
Sergakis, Konstantinos
core  

Two Faces of NOTCH1 in Childhood Lymphoblastic T‐Cell Neoplasia: Prognostic Divergence of Mutational and Structural Aberrations

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT In pediatric patients, T‐cell lymphoblastic lymphoma (T‐LBL) survival exceeds 80%. Relapse remains associated with limited curative options. Frontline treatment is largely extrapolated from T‐cell acute lymphoblastic leukemia (T‐ALL) treatment, reflecting the ongoing debate, whether both entities represent distinct diseases or variants within ...
Marie C. Heider   +4 more
wiley   +1 more source

Crime and Sanctions: Beyond Sanctions as a Foreign Policy Tool

open access: yesGerman Law Journal
Targeted sanctions, namely asset freezes and travel bans, are no longer the province of foreign policy alone. They are increasingly often used by governments in response to crime, such as corruption, human rights abuse, cybercrime, drug trafficking, and ...
Anton Moiseienko
doaj   +1 more source

Targeted Sanctions: a Tool of Foreign Policy, Unfair Competition or Global Social Engineering?

open access: yesVestnik MGIMO-Universiteta, 2019
Through the recent decades, the use of asymmetric and hybrid measures in international relations has acquired a qualitatively new scale and system. Today such measures have turned into one of the leading forms of external pressure and subsequent coercion,
L. L. Fituni
doaj   +1 more source

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Blinatumomab is a bispecific T‐cell engager approved for the treatment of pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). Outpatient home infusion reduces hospitalization burden and optimizes resource utilization, but is logistically challenging.
Angela Parra del Riego   +10 more
wiley   +1 more source

The Ethics of International Sanctions: The Case of Yugoslavia [PDF]

open access: yes, 2000
Sanctions such as those applied by the United Nations against Yugoslavia, or rather the actions of implementing and maintaining them, at the very least implicitly purport to have moral justification. While the rhetoric used to justify sanctions
Babić, Jovan, Jokic, Aleksandar
core  

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy